SARAH HELMS: Open Payments
NPI 1083964290 · DALLAS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,661 in 125 payments from 26 companies in 2025. Trend: 2023 $2,395 · 2024 $1,986 · 2025 $2,661
Food & beverage: $2,647Entertainment: $14
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $582 |
| Bayer Healthcare Pharmaceuticals Inc. | 21 | $330 |
| Gilead Sciences, Inc. | 14 | $321 |
| Novo Nordisk Inc | 8 | $207 |
| Amgen Inc. | 5 | $172 |
| ViiV Healthcare Company | 6 | $153 |
| AstraZeneca Pharmaceuticals LP | 6 | $115 |
| PFIZER INC. | 6 | $111 |
| Lilly USA, LLC | 5 | $89 |
| GlaxoSmithKline, LLC. | 3 | $82 |
Products named: Kerendia, VRAYLAR, CABENUVA, UBRELVY, Ozempic, QULIPTA, TRELEGY ELLIPTA, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
